We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.65B
AUM Growth
+$68.2M
Cap. Flow
+$105M
Cap. Flow %
3.99%
Top 10 Hldgs %
43.52%
Holding
66
New
14
Increased
16
Reduced
21
Closed
14

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$122M
2
ZBH icon
Zimmer Biomet
ZBH
+$96.2M
3
BAX icon
Baxter International
BAX
+$88.2M
4
BIIB icon
Biogen
BIIB
+$83.1M
5
LH icon
Labcorp
LH
+$80.4M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$161M
2
ELAN icon
Elanco Animal Health
ELAN
+$97.3M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$82M
4
AMRN
Amarin Corp
AMRN
+$59.1M
5
ALGN icon
Align Technology
ALGN
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 90.28%
2 Technology 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENT
26
DELISTED
Intersect ENT, Inc
XENT
$43.2M 1.63%
2,541,630
-234,265
-8% -$4.26M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$42.5M 1.61%
2,062,360
+1,962,360
+1,962% +$46.7M
CNMD icon
28
CONMED
CNMD
$1.55B
$41M 1.55%
426,910
-28,280
-6% -$2.65M
IQV icon
29
IQVIA
IQV
$38.4B
$40.9M 1.55%
273,950
+18,006
+7% +$2.8M
HOLX
30
DELISTED
Hologic
HOLX
$40.9M 1.55%
+809,570
New +$39.8M
BSX icon
31
Boston Scientific
BSX
$72B
$39.1M 1.48%
961,820
-509,550
-35% -$21.6M
ALC icon
32
Alcon
ALC
$34.2B
$32.6M 1.23%
558,940
+32,100
+6% +$1.93M
GILD icon
33
Gilead Sciences
GILD
$163B
$30.6M 1.16%
482,930
-280,370
-37% -$18.3M
HAE icon
34
Haemonetics
HAE
$3.94B
$26.7M 1.01%
211,670
-138,520
-40% -$17.6M
BMY icon
35
CALL
Bristol-Myers Squibb
BMY
$134B
$20.3M 0.77%
400,000
-200,000
-33% -$9.4M
QGEN icon
36
Qiagen
QGEN
$8.73B
$20.2M 0.77%
+579,140
New +$22.3M
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
$19.1M 0.72%
300,905
+51,185
+20% +$3.2M
SYK icon
38
Stryker
SYK
$131B
$18.8M 0.71%
87,090
+53,740
+161% +$11.5M
HUM icon
39
Humana
HUM
$45B
$17.9M 0.68%
70,070
-574,790
-89% -$161M
MYOK
40
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$14.7M 0.56%
282,090
-68,530
-20% -$3.64M
VRAY
41
DELISTED
ViewRay, Inc.
VRAY
$14.2M 0.54%
4,890,100
+325,460
+7% +$1.93M
GMAB icon
42
Genmab
GMAB
$17.6B
$14.1M 0.53%
+696,835
New +$13.7M
SEM
43
DELISTED
Select Medical
SEM
$13.7M 0.52%
1,531,014
-334,080
-18% -$2.92M
STML
44
DELISTED
Stemline Therapeutics, Inc.
STML
$12.9M 0.49%
1,243,780
+173,820
+16% +$2.27M
NVST icon
45
Envista
NVST
$4.45B
$8.36M 0.32%
+300,000
New +$8.38M
SRGA
46
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6.15M 0.23%
+71,955
New +$7.68M
CLVS
47
DELISTED
Clovis Oncology, Inc.
CLVS
$5.86M 0.22%
1,491,376
-156,714
-10% -$1.27M
ZGNX
48
DELISTED
Zogenix, Inc.
ZGNX
$5.25M 0.2%
+130,990
New +$6.04M
AUPH icon
49
Aurinia Pharmaceuticals
AUPH
$1.87B
$4.45M 0.17%
+832,370
New +$5.04M
NGM
50
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.39M 0.17%
316,679
-25,900
-8% -$389K
1
2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2019 Portfolio in Review

As of Q3 2019, HealthCor Management held 66 positions worth $2.65B, up 2.6% from $2.58B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

HealthCor Management deployed $105M of net new capital in Q3 2019, opening 14 new positions and adding to 16 existing holdings. Its largest new stake was Intuitive Surgical: 705,615 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Humana, an estimated $161M trimmed.

  • HealthCor Management's largest Q3 2019 buy was Intuitive Surgical: 705,615 shares worth $127M.
  • HealthCor Management added most to Wright Medical Group Inc in Q3 2019, an estimated $46.7M increase.
  • HealthCor Management's biggest Q3 2019 reduction was Humana, cutting an estimated $161M.
  • HealthCor Management fully exited Elanco Animal Health in Q3 2019, selling an estimated $97.3M.
  • HealthCor Management's ten largest holdings make up 44% of its $2.65B portfolio in Q3 2019.
  • HealthCor Management opened 14 new positions and closed 14 in Q3 2019.
  • HealthCor Management's portfolio value rose 2.6% quarter-over-quarter to $2.65B.

Based on HealthCor Management's 13F filing for Q3 2019, filed 14 Nov 2019.